Home > Financial Ratios > ORCHID PHARMA

ORCHID PHARMA
EV/EBIT

    Back to All Ratios
AD     Remove this Ad

ORCHID PHARMA Last 5 Year EV/EBIT History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/EBIT(x) 35.6147.5621.21-60.59-243.82

What is the latest EV/EBIT ratio of ORCHID PHARMA ?

The latest EV/EBIT ratio of ORCHID PHARMA is 35.61 based on Mar2025 Consolidated results.
Year EV/EBIT
Mar202535.61
Mar202447.56
Mar202321.21
Mar2022-60.59
Mar2021-243.82

How is EV/EBIT of ORCHID PHARMA Trending?

Years EV/EBIT % Change
Mar2025 35.61
-25.13
Mar2024 47.56
124.23
Mar2023 21.21
Positive
Mar2022 -60.59
Negative
Mar2021 -243.82 -

Other Financial Ratios of ORCHID PHARMA


Compare EV/EBIT ratio of peers of ORCHID PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ORCHID PHARMA ₹3,142.6 Cr -6.8% -11.3% -31.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹417,028.0 Cr 0.3% 9% 8.6% Stock Analytics
DIVIS LABORATORIES ₹170,237.0 Cr 1.9% 5.9% 12.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹146,801.0 Cr 0.6% 9.5% 45% Stock Analytics
CIPLA ₹108,861.0 Cr 1.6% 1.8% -7.9% Stock Analytics
DR REDDYS LABORATORIES ₹107,435.0 Cr -1.5% 5.7% 14.5% Stock Analytics


ORCHID PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ORCHID PHARMA

-6.8%

-11.3%

-31.6%

SENSEX

-1.8%

-1.6%

7.3%


You may also like the below Video Courses